A Jacobi, G Shuler, M Hertl. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAntibodies, Monoclonal/therapeutic useDermatologic Agents/therapeutic useHumansInfliximabMaleMouth Mucosa/drug effectsPemphigus/drug therapyTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalDermatologic AgentsTumor Necrosis Factor-alphaInfliximab
Year: 2005 PMID: 16086769 DOI: 10.1111/j.1365-2133.2005.06744.x
Source DB: PubMed Journal: Br J Dermatol ISSN: 0007-0963 Impact factor: 9.302